Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
With
Ono Pharmaceutical Co., Ltd.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Previously treated advanced/metastatic NSCLC patients treated with nivolumab at least once from 01-Apr-2016 through 31-Dec-2016
History of participation in any clinical trials prior- or post-nivolumab treatment
Patients who are a part of a Post-marketing surveillance study
Clareo Health | A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Japan
